This mutation was previously associated with brain development anomalies in a mouse model, suggesting that this phenotype could also be a result of this mutation and further expanding the phenotypic spectrum of PAX2 heterozygous mutations to include autosomal dominant childhood-onset focal segmental glomerulosclerosis [48]. The gene discussed is PAX2; the disease is focal segmental glomerulosclerosis.